Plastic Surgery International / 2018 / Article / Tab 1


Corrigendum to “Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years”

Table 1

Patient collective with ADM-implementation.

ADMProductNumber of ADM implants usedNumber of treated patientsMedian patient age (years)Median follow-up time (months)

HADMEpiflex® / DIZG151246 (36-76)40 (20-50)
PADMStrattice® / LifeCell211656 (44-66)43 (30-54)
BADMTutomesh® / rti surgical161353 (33-74)20 (12-31)

totalall ADMs524152 (33-76)36 (12-54)

Listing of matrix, name of ADM-product and its fabricant, amount of breast reconstructions (BR)/augmentations with usage of ADMs, number of patients treated with ADMs, median patient age and range in years, and median follow-up time and range in months of the given patient collective, which received a breast reconstruction/augmentation with ADM; HADM: human ADM; PADM: porcine ADM; and BADM: bovine ADM.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.